Clipan Finance Indonesia Tbk PT
IDX:CFIN
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
304
520
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Clipan Finance Indonesia Tbk PT
Current Assets | 507.7B |
Cash & Short-Term Investments | 28.8B |
Receivables | 471.1B |
Other Current Assets | 7.7B |
Non-Current Assets | 9.7T |
Long-Term Investments | 13.2B |
PP&E | 205.6B |
Intangibles | 12.5B |
Other Non-Current Assets | 9.5T |
Current Liabilities | 423.4B |
Accounts Payable | 61.7B |
Accrued Liabilities | 83B |
Other Current Liabilities | 278.7B |
Non-Current Liabilities | 4.1T |
Long-Term Debt | 4.1T |
Other Non-Current Liabilities | 89.4B |
Balance Sheet
Clipan Finance Indonesia Tbk PT
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
35 768
|
30 396
|
30 323
|
28 547
|
53 011
|
104 365
|
0
|
0
|
0
|
32 721
|
|
Cash Equivalents |
35 768
|
30 396
|
30 323
|
28 547
|
53 011
|
104 365
|
0
|
0
|
0
|
32 721
|
|
Total Receivables |
1 884 574
|
1 394 169
|
1 323 099
|
1 190 288
|
1 200 039
|
1 132 471
|
1 110 180
|
544 618
|
427 189
|
407 626
|
|
Accounts Receivables |
0
|
66 314
|
0
|
0
|
0
|
0
|
0
|
0
|
55 187
|
33 147
|
|
Other Receivables |
0
|
1 460 483
|
0
|
0
|
0
|
0
|
0
|
0
|
372 001
|
374 479
|
|
Other Current Assets |
8 254
|
7 768
|
12 933
|
16 126
|
14 595
|
21 584
|
3 662
|
1 345
|
3 700
|
5 139
|
|
Total Current Assets |
1 928 595
|
1 432 333
|
1 366 355
|
1 234 962
|
1 267 644
|
1 258 420
|
3 038 627
|
672 744
|
462 215
|
445 486
|
|
PP&E Net |
70 239
|
121 974
|
136 647
|
153 842
|
187 227
|
200 926
|
198 491
|
188 618
|
217 608
|
207 321
|
|
PP&E Gross |
70 239
|
121 974
|
136 647
|
153 842
|
187 227
|
200 926
|
198 491
|
188 618
|
217 608
|
207 321
|
|
Accumulated Depreciation |
53 492
|
6 819
|
16 731
|
33 627
|
11 860
|
31 087
|
52 015
|
19 107
|
34 318
|
49 470
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
16 864
|
18 462
|
15 462
|
15 570
|
15 689
|
13 637
|
|
Note Receivable |
4 584 086
|
5 047 429
|
5 109 294
|
8 429 317
|
9 558 820
|
10 587 324
|
7 609 172
|
5 863 808
|
7 067 590
|
8 957 486
|
|
Long-Term Investments |
22 871
|
10 437
|
92 063
|
21 303
|
22 849
|
12 457
|
12 457
|
13 224
|
13 224
|
13 224
|
|
Other Long-Term Assets |
5 963
|
4 737
|
76
|
4 750
|
19 620
|
31 371
|
40 174
|
97 432
|
66 942
|
70 749
|
|
Other Assets |
29 636
|
29 762
|
39 756
|
46 674
|
30 254
|
8 519
|
3 073
|
272 508
|
205 987
|
203 351
|
|
Total Assets |
6 641 391
N/A
|
6 646 672
+0%
|
6 744 190
+1%
|
9 890 847
+47%
|
11 103 279
+12%
|
12 117 478
+9%
|
10 917 456
-10%
|
7 123 904
-35%
|
8 049 256
+13%
|
9 911 254
+23%
|
|
Liabilities | |||||||||||
Accounts Payable |
36 171
|
12 270
|
32 675
|
130 571
|
101 884
|
79 108
|
28 638
|
76 790
|
143 109
|
93 056
|
|
Accrued Liabilities |
20 466
|
21 381
|
20 223
|
39 943
|
54 418
|
57 884
|
28 771
|
37 156
|
56 399
|
52 250
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
589 979
|
264 938
|
470 000
|
625 000
|
340 000
|
380 000
|
15 000
|
0
|
165 248
|
465 389
|
|
Other Current Liabilities |
161 060
|
123 054
|
130 069
|
181 148
|
226 353
|
235 047
|
139 560
|
146 411
|
156 625
|
106 619
|
|
Total Current Liabilities |
807 676
|
421 643
|
652 967
|
976 662
|
722 656
|
752 039
|
211 970
|
260 357
|
521 381
|
717 314
|
|
Long-Term Debt |
2 564 749
|
2 608 858
|
2 272 189
|
4 851 830
|
5 958 439
|
6 568 252
|
5 879 296
|
1 992 695
|
2 331 623
|
3 564 505
|
|
Other Liabilities |
13 287
|
17 243
|
20 103
|
32 824
|
75 059
|
91 506
|
81 001
|
64 732
|
85 169
|
102 677
|
|
Total Liabilities |
3 385 712
N/A
|
3 047 744
-10%
|
2 945 259
-3%
|
5 861 317
+99%
|
6 756 154
+15%
|
7 411 796
+10%
|
6 172 266
-17%
|
2 317 784
-62%
|
2 938 173
+27%
|
4 384 496
+49%
|
|
Equity | |||||||||||
Common Stock |
996 130
|
996 130
|
996 130
|
996 130
|
996 130
|
996 130
|
996 130
|
996 130
|
996 130
|
996 130
|
|
Retained Earnings |
1 910 083
|
2 196 656
|
2 404 621
|
2 643 835
|
2 952 153
|
3 326 537
|
3 362 613
|
3 413 061
|
3 724 099
|
4 144 100
|
|
Additional Paid In Capital |
351 949
|
351 949
|
351 949
|
351 949
|
351 949
|
351 949
|
351 949
|
351 949
|
351 949
|
351 949
|
|
Unrealized Security Profit/Loss |
0
|
56 690
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
2 482
|
2 497
|
46 232
|
37 617
|
46 893
|
31 066
|
34 498
|
44 980
|
38 905
|
34 579
|
|
Total Equity |
3 255 679
N/A
|
3 598 928
+11%
|
3 798 931
+6%
|
4 029 531
+6%
|
4 347 125
+8%
|
4 705 682
+8%
|
4 745 190
+1%
|
4 806 120
+1%
|
5 111 083
+6%
|
5 526 758
+8%
|
|
Total Liabilities & Equity |
6 641 391
N/A
|
6 646 672
+0%
|
6 744 190
+1%
|
9 890 847
+47%
|
11 103 279
+12%
|
12 117 478
+9%
|
10 917 456
-10%
|
7 123 904
-35%
|
8 049 256
+13%
|
9 911 254
+23%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
3 775
|
3 985
|
3 985
|
3 985
|
3 985
|
3 985
|
3 985
|
3 985
|
3 985
|
3 985
|